In clinical trials, recombinant human IGF-1 can improve abnormal respiratory movement, cognitive ability, irritability, and anxiety in RTT patients (Pini et al., 2012; Khwaja et al., 2014). This evidence concerns the gene IGF1 and Anxiety.